Suven Pharmaceuticals Limited

Informe acción NSEI:SUVENPHAR

Capitalización de mercado: ₹337.0b

Salud financiera de hoja de balance de Suven Pharmaceuticals

Salud financiera controles de criterios 6/6

Suven Pharmaceuticals tiene un patrimonio de accionistas total de ₹20.5B y una deuda total de ₹650.0M, lo que sitúa su ratio deuda-patrimonio en 3.2%. Sus activos y pasivos totales son ₹22.5B y ₹2.0B respectivamente. El BAIT de Suven Pharmaceuticals es de ₹2.7B, por lo que su ratio de cobertura de intereses es de 51.4. Tiene efectivo e inversiones a corto plazo que ascienden a ₹8.2B.

Información clave

3.2%

Ratio deuda-patrimonio

₹649.96m

Deuda

Ratio de cobertura de intereses51.4x
Efectivo₹8.21b
Patrimonio₹20.51b
Total pasivo₹2.03b
Activos totales₹22.54b

Actualizaciones recientes sobre salud financiera

Recent updates

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Dec 15
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Aug 03
Robust Earnings May Not Tell The Whole Story For Suven Pharmaceuticals (NSE:SUVENPHAR)

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

May 12
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Mar 26
Suven Pharmaceuticals Limited (NSE:SUVENPHAR) Investors Are Less Pessimistic Than Expected

Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

Mar 07
Here's Why We Think Suven Pharmaceuticals (NSE:SUVENPHAR) Is Well Worth Watching

These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Nov 30
These 4 Measures Indicate That Suven Pharmaceuticals (NSE:SUVENPHAR) Is Using Debt Safely

Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Sep 03
Do Suven Pharmaceuticals's (NSE:SUVENPHAR) Earnings Warrant Your Attention?

Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Aug 04
Here's Why Suven Pharmaceuticals (NSE:SUVENPHAR) Can Manage Its Debt Responsibly

Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

Jun 11
Analysts Have Made A Financial Statement On Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) Full-Year Report

With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Apr 13
With EPS Growth And More, Suven Pharmaceuticals (NSE:SUVENPHAR) Is Interesting

Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Mar 08
Does Suven Pharmaceuticals (NSE:SUVENPHAR) Have A Healthy Balance Sheet?

Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

Feb 08
Can Suven Pharmaceuticals Limited's (NSE:SUVENPHAR) ROE Continue To Surpass The Industry Average?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹12.6B) de SUVENPHAR superan a sus pasivos a corto plazo (₹1.1B).

Pasivo a largo plazo: Los activos a corto plazo de SUVENPHAR (₹12.6B) superan a sus pasivos a largo plazo (₹965.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: SUVENPHAR tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de SUVENPHAR ha pasado de 16.6% a 3.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de SUVENPHAR está bien cubierta por el flujo de caja operativo (551.5%).

Cobertura de intereses: Los pagos de intereses de la deuda de SUVENPHAR están bien cubiertos por el BAIT (51.4x cobertura).


Hoja de balance


Descubre empresas con salud financiera